Skip to content

Effect of Pyridoxine(Vitamin B6) in control of vomiting

Effect of Pyridoxine(Vitamin B6) in control of vomiting due to acute gastroenteritis in children 6 month to 12 years

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201108167342N1
Enrollment
140
Registered
2012-01-17
Start date
2011-09-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vomiting. Nausea and vomiting

Interventions

Intervention 1: Case group: pyridoxine 2mg/kg (max 60 mg) IV, stat, at admission. Frequency of vomiting and days of admission are calculated. Intervention 2: Control group: parenteral rehydration with
Treatment - Drugs
Placebo
Case group: pyridoxine 2mg/kg (max 60 mg) IV, stat, at admission. Frequency of vomiting and days of admission are calculated.
Control group: parenteral rehydration with placebo (1 ml distilled water) IV at admission. Frequency of vomiting and days of admission are calculated.

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1.6 month to 12 years old child. 2.Acute viral gastroenteritis with vomiting. 3.No treatment before admission. 4.Completed consent form. Exclusion criteria: 1.Severe dehydration. 2.Abnormal finding in stool exam (RBC, WBC, parasite). 3.Acute abdomen. 4.Patient withdrew from the project. 5.Discharge the patient with personal satisfaction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Frequency of vomiting. Timepoint: 8 hour before admition,first day,second day,third day of admition. Method of measurement: Frequency of vomiting with questionnaire.

Secondary

MeasureTime frame
Dayes of admition. Timepoint: day. Method of measurement: dayes of admition with quetionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParsa Yousefi

Arak University of Medical Sciences and Health Services research

parsayousefichaijan@yahoo.com+98 86 1313 5075

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026